OPKO Health (OPK) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts OPK Hot Sheet
Price: $1.53 +1.32%
Revenue Growth %: -13.1%
Financial Fact:
Net loss attributable to common Shareholders: -14.98M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: -13.1%
Financial Fact:
Net loss attributable to common Shareholders: -14.98M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
OPKO Health (NYSE: OPK) reported Q4 EPS of $0.00, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $276.2 million versus the consensus estimate of $286.52 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Farmmi announces public offering of Class A ordinary shares
- Freedom Broker Starts Copart (CPRT) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
